$33.00
Manufacturer: Poland
Viral infections caused by herpes simplex virus type 1 and 2, chickenpox virus, cytomegalovirus, Epstein-Barr virus, measles virus, mumps virus, including in patients with immunodeficiency conditions; viral respiratory infection; papillomavirus infection of the skin and mucous membranes: genital warts, papillomavirus infection of the vulva, vagina and cervix (as part of complex therapy); acute viral encephalitis (as part of complex therapy); viral hepatitis (as part of complex therapy); subacute sclerosing panencephalitis (as part of complex therapy).
Description
Groprinozin Composition
active substance: inosine pranobex
1 tablet contains 500 mg of inosine pranobex
excipients: potato starch, povidone, magnesium stearate.
Groprinozin Dosage form
Pills.
Groprinozin Pharmacological group
Direct-acting antiviral agents. ATC code J05A X05.
Indications
Infectious diseases of viral etiology in patients with normal and low immune status: influenza, parainfluenza, acute respiratory viral infections, bronchitis of viral etiology, rhinoviral and adenoviral infections, mumps, measles
diseases caused by herpes simplex viruses Herpes simplex type I or Herpes simplex type II (herpes of the lips, facial skin, oral mucosa, skin of the hands, ophthalmic herpes), subacute sclerosing panencephalitis, genital herpes with the Varicella zoster virus (chickenpox and shingles, in including recurrent in patients with immunodeficiency) Epstein-Barr virus (infectious mononucleosis) cytomegalovirus human papillomavirus acute and chronic viral hepatitis B
chronic recurrent infections of the respiratory tract and genitourinary system in immunocompromised patients (including chlamydia and other diseases caused by intracellular pathogens).
Contraindications
Hypersensitivity to the active substance or to any of the excipients of the drug
acute gout attack
hyperuricemia.
Method of administration and dosage
The drug is taken orally, preferably after a meal, at regular intervals, if necessary, the tablet can be chewed, crushed and / or dissolved in a small amount of water immediately before use. The duration of treatment is determined individually, depending on the nosology, the severity of the process and the frequency of relapses, on average, the duration of treatment is 5-14 days, if necessary, after a 7-10-day break, the course of treatment is repeated. Treatment with interruptions and maintenance doses can last up to 1-6 months.
The maximum daily dose is 4 g (8 tablets of 500 mg).
Recommended doses and dosage regimens of the drug:
influenza, parainfluenza, acute respiratory viral infections:
Adults – 2 tablets 3-4 times a day; children – a daily dose of 50 mg / kg of body weight in 3-4 doses for 5-7 days, if necessary, continue treatment or repeat after 7-8 days. To achieve the greatest efficiency in acute respiratory viral infections, it is better to start treatment at the first symptoms of the disease or from the first day of the disease. As a rule, the drug is taken for another 1-2 days after the symptoms disappear.
Recent Reviews